mixed amphetamine salts / amphetamines Drug Test Guide: Panels, Detection Windows & More

Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated August 2026

Quick answer: Stimulant (amphetamine / dextroamphetamine / lisdexamfetamine) — included on the federal 5-panel. Urine detects it roughly 1–3 days; hair archives ~90 days; saliva and blood track only recent use. Urine: 500 ng/mL initial screen; GC–MS confirm at 250 ng/mL requiring d-amphetamine (methamphetamine confirm additionally requires methamphetamine ≥250 ng/mL).

Overview

This guide covers everything verifiable about how testing handles mixed amphetamine salts / amphetamines (also searched as: mixed amphetamine salts, lisdexamfetamine, dextroamphetamine, speed): which panels include it, detection windows across specimens, cutoff levels, false-positive risks, and legitimate prescription handling.

Panel membership

PanelAmphetamines status
5-Panel✅ Included
10-Panel✅ Included
12-Panel✅ Included
DOT 5-panel (safety-sensitive)✅ Included

Detection windows

Ranges reflect occasional-to-heavy use patterns from FDA device inserts and SAMHSA-certified lab conventions.
Test typeTypical Amphetamines detection window
Urineoccasional: 1–3 days · regular: up to 4–5 days
Saliva (Mouth Swab)any: 1–2 days (20–50 hours)
Hair Folliclesup to 90 days
Bloodany: ~12–24 hours

Cutoff levels

Urine: 500 ng/mL initial screen; GC–MS confirm at 250 ng/mL requiring d-amphetamine (methamphetamine confirm additionally requires methamphetamine ≥250 ng/mL).

Cutoffs exist to separate real use from noise — dietary exposure, passive contact and legacy medications stay below them by design. Screen-above-cutoff results still require mass-spec confirmation before reporting.

Deep-dive facts

Amphetamines are on every standard panel including the federal 5-panel. A prescription does not exempt you — it explains the result. Take your prescription (or pharmacy printout) to the collection site or have it ready for the Medical Review Officer call; verified prescriptions are reported as negative.

lisdexamfetamine is a prodrug: your body converts lisdexamfetamine into d-amphetamine after ingestion, so it produces a normal amphetamine-positive result indistinguishable timing-wise from mixed amphetamine salts.

Illicit methamphetamine also breaks down into amphetamine, which is why meth confirmations require both methamphetamine and its metabolite amphetamine above thresholds — separating prescription-amp users from meth users.

Typical therapeutic doses of mixed amphetamine salts clear urine in 1–3 days; larger or prolonged doses push toward 4–5 days. There is no realistic same-day trick; hydration dilution risks a 'dilute' flagged specimen instead.

False positives & cross-reactivity

  • Documented amphetamine-screen cross-reactants include bupropion (bupropion), labetalol, phentermine, pseudoephedrine/pseudoephedrine decongestants, methylphenidate (some assays), trazodone, selegiline, and promethazine — immunoassay positives only; GC–MS confirmation distinguishes them.
  • Phentermine is a genuine amphetamine-class result on many assays rather than a false one — disclose it.
Source basis: Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 plus FDA assay inserts. GC–MS/LC–MS confirmation eliminates these artifacts.
Screen flaggedDocumented cross-reactants (immunoassay tier only)
AmphetaminesBupropion (bupropion), trazodone, phentermine, pseudoephedrine, labetalol, promethazine, methylphenidate
PCPDextromethorphan (dextromethorphan cough syrup), diphenhydramine (diphenhydramine), doxylamine (multi-symptom cold remedies), tramadol, venlafaxine (venlafaxine), ketamine
OpiatesPoppy seeds (true positive), quinine, dextromethorphan, ofloxacin/levofloxacin, rifampin
BenzodiazepinesSertraline (sertraline), oxaprozin (case reports)
MethadoneDiphenhydramine, doxylamine, verapamil, quetiapine (quetiapine), clomipramine
Tricyclics (TCA)Cyclobenzaprine (cyclobenzaprine), hydroxyzine, carbamazepine, diphenhydramine
Cannabinoids (THC)Efavirenz, pantoprazole (isolated reports); dronabinol/dronabinol = true positive

Legal status note

Schedule II by prescription (ADHD, narcolepsy).

Popular guides in this series

Certified labs nationwide · Results in 1–2 days

Need a test? Order online, test same-day →
Medical disclaimer: DrugPanels provides educational information about laboratory drug testing and does not offer medical advice, diagnosis, or treatment. Detection windows are population ranges — individual results vary with metabolism, dose, frequency and health status. Never stop prescribed medication to pass a test without talking to your prescriber. Affiliate disclosure: some links on this page are affiliate links; if you order through them we may earn a commission at no additional cost to you.

People also ask

Does mixed amphetamine salts Show up Drug Test?

Yes — Amphetamines appears on standard drug panels. Full guide →

How Long Do Amphetamines Stay in Your System?

How long Amphetamines stays detectable in your system (all test types) — urine, hair, saliva & blood windows explained with cutoffs. Full guide →

How Long Do Amphetamines Stay Detectable in Urine?

How long Amphetamines stays detectable in urine — urine, hair, saliva & blood windows explained with cutoffs. Full guide →

Will mixed amphetamine salts Make You Fail a Drug Test?

Can Amphetamines trigger a false positive? Cross-reactivity evidence, confirmation testing, and how to clear your name with the MRO. Full guide →

How accurate are drug tests?

Lab-based immunoassay screens agree with confirmation testing ~97% of the time; confirmed GC–MS results are considered definitive. Home kits trade legal defensibility for convenience.

Do prescriptions count against me?

No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.

Sources & further reading

  • SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
  • DOT — 49 CFR Part 40 procedures for transportation workplace testing
  • Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
  • FDA — drug-of-abuse test device labeling (detection window conventions)